Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        


Read More News and Insights

CBD Could Help Prevent and Treat Graft-Versus-Host Disease

Z-ARCHIVE-Cannabis Patent Forecast®

May 28, 2020

In a patent (US Pat. No. 10,660,865) issued this week assigned to Mor Research Applications and STERO Biotechs, CBD is described as being capable of preventing and treating Graft-Versus-Host Disease (GVHD). When someone receives a tissue transplant, if the tissue contains immune cells, they may attack the host's tissues, known as a graft-vs-host reaction. 

Patent ‘865 teaches a method of preventing and treating a patient with GVHD that will undergo an allogeneic hematopoietic stem cell transplant - a transplant from a related donor or from someone with a similar genetic makeup. A drug containing CBD, cyclosporine, and immunosuppressive drugs is administered to the patient 14 days before the transplant process and either 1 to 30 days or 7 to 180 days after the procedure. 

Mor Research Applications is the Technology Transfer Office of Clalit Health Services and is based in Tel Aviv, IL and was created in partnership with STERO Biotechs, a clinical stage company focused on R&D of novel CBD therapies, also based in Israel. Explore cannabis-based pharmaceuticals and compositions using Magic Number’s Cannabis Patent Forecast®.   

Blood, Cells, Red, Medical, Medicine, Anatomy, Health

Relevant Patent Documents

Patent US10660865  

Read more like this in News This Week!   or   Share this link with your connections!